Human Genome Epidemiology Literature Finder
Records 1 - 7 (of 7 Records) |
Query Trace: Acromegaly and IGF1[original query] |
---|
D3 GH receptor polymorphism is not associated with IGF1 levels in untreated acromegaly. European journal of endocrinology / European Federation of Endocrine Societies 2009 Aug 161 (2): 231-5. Kamenicky Peter, Dos Santos Christine, Espinosa Consuelo, Salenave Sylvie, Galland Françoise, Le Bouc Yves, Maison Patrick, Bougnères Pierre, Chanson Philip |
Role of IGF1-(CA)19 promoter microsatellite in the clinical presentation of acromegaly. European journal of clinical investigation 2014 Dec 44 (12): 1222-9. Sala Elisa, Filopanti Marcello, Ferrante Emanuele, Barbieri Anna Maria, Malchiodi Elena, Verrua Elisa, Giavoli Claudia, Lania Andrea G, Arosio Maura, Beck-Peccoz Paolo, Spada Anna, Mantovani Giovan |
Analysis of IGF(CA)19 and IGFBP3-202A/C gene polymorphisms in patients with acromegaly: association with clinical presentation and response to treatments. European journal of endocrinology / European Federation of Endocrine Societies 2015 Feb 172 (2): 115-22. Ramos-Leví Ana M, Marazuela Mónica, Paniagua Amalia, Quinteiro Celsa, Riveiro Javier, Álvarez-Escolá Cristina, Lúcas Tomás, Blanco Concepción, de Miguel Paz, Martínez de Icaya Purificación, Pavón Isabel, Bernabeu Ignac |
Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3. European journal of endocrinology / European Federation of Endocrine Societies 2015 Aug . Franck Sanne Elisabeth, Van der Lely A J, Delhanty Patric J, Jorgensen Jens Otto L, Neggers Sebastian J C M |
Investigation of the vitamin D receptor polymorphisms in acromegaly patients. BioMed research international 2015 2015 625981. Ilhan Muzaffer, Toptas-Hekimoglu Bahar, Yaylim Ilhan, Turgut Seda, Turan Saime, Karaman Ozcan, Tasan Ertugr |
Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly. Pituitary 2015 Oct 18 (5): 666-73. Jallad Raquel S, Trarbach Ericka B, Duarte Felipe H, Jorge Alexander A L, Bronstein Marcello |
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. Endocrine 2017 Aug . Chiloiro S, Mormando M, Bianchi A, Giampietro A, Milardi D, Bima C, Grande G, Formenti A M, Mazziotti G, Pontecorvi A, Giustina A, De Marinis |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: